| scholarly article | Q13442814 |
| P50 | author | Rajendra Sawh-Martinez | Q48299301 |
| Christopher K. Breuer | Q55221597 | ||
| P2093 | author name string | Narutoshi Hibino | |
| Tai Yi | |||
| Tamar L Mirensky | |||
| Toshiharu Shinoka | |||
| Gustavo Villalona | |||
| P2860 | cites work | First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo | Q30980855 |
| Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model | Q36645337 | ||
| Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo. | Q36950991 | ||
| Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model | Q37304957 | ||
| Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings | Q37683180 | ||
| Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression | Q40868885 | ||
| Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model | Q43708239 | ||
| Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices | Q44315262 | ||
| Tissue-engineered arterial grafts: long-term results after implantation in a small animal model | Q45718471 | ||
| Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells | Q46533885 | ||
| Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. | Q51240195 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1299-1305 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Journal of Pediatric Surgery | Q15761821 |
| P1476 | title | Tissue-engineered vascular grafts: does cell seeding matter? | |
| P478 | volume | 45 |
| Q27306934 | A cautionary tale for autologous vascular tissue engineering: impact of human demographics on the ability of adipose-derived mesenchymal stem cells to recruit and differentiate into smooth muscle cells. |
| Q35609601 | A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts |
| Q89893746 | Biodegradable Extremely-Small-Diameter Vascular Graft Made of Silk Fibroin can be Implanted in Mice |
| Q53633409 | Bioengineered blood vessels. |
| Q52399862 | Biomaterial-driven in situ cardiovascular tissue engineering-a multi-disciplinary perspective. |
| Q56376510 | Biomaterials and heart recovery: cardiac repair, regeneration and healing in the MCS era: a state of the "heart" |
| Q35993782 | Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model |
| Q35609635 | Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI |
| Q50970925 | Determining the optimal protocol for preparing an acellular scaffold of tissue engineered small-diameter blood vessels. |
| Q37419312 | Development and in vivo evaluation of small-diameter vascular grafts engineered by outgrowth endothelial cells and electrospun chitosan/poly(ε-caprolactone) nanofibrous scaffolds |
| Q35667383 | Evaluation of polycaprolactone scaffold with basic fibroblast growth factor and fibroblasts in an athymic rat model for anterior cruciate ligament reconstruction. |
| Q57177288 | Future Perspectives on the Role of Stem Cells and Extracellular Vesicles in Vascular Tissue Regeneration |
| Q34293482 | Implantation of inferior vena cava interposition graft in mouse model |
| Q57175348 | In Vivo Performance of Decellularized Vascular Grafts: A Review Article |
| Q89017816 | Labeling of endothelial cells with magnetic microbeads by angiophagy |
| Q89442201 | Magnetic Resonance Imaging of Shear Stress and Wall Thickness in Tissue-Engineered Vascular Grafts |
| Q37849650 | Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? |
| Q37438427 | Nerve regeneration and elastin formation within poly(glycerol sebacate)-based synthetic arterial grafts one-year post-implantation in a rat model |
| Q58562094 | Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease |
| Q34124603 | Short stimulation of electro-responsive PAA/fibrin hydrogel induces collagen production |
| Q50869516 | The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft. |
| Q38253653 | Tissue engineered scaffolds for an effective healing and regeneration: reviewing orthotopic studies. |
| Q38817609 | Tissue engineered vascular grafts: current state of the field. |
| Q36062796 | Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again |
| Q52345373 | Toward a patient-specific tissue engineered vascular graft. |
| Q34674589 | Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model |
Search more.